Pioneering technologies that create novel antibody therapeutics to treat cancer and other serious diseases.
Research
Innovation
Discover how ÐǺ£ÆåÅÆ makes a positive impact for patients, communities, employees and the environment
Corporate and financial resources for ÐǺ£ÆåÅÆ investors, potential shareholders and analysts
Resources
Financials
Stock Information
Governance
Our Science
Our Medicines
ÐǺ£ÆåÅÆ’s science is behind multiple medicines.
This page is using US and EU product trade names (where available) with accompanying generic names. These names may differ in other countries. Our medicines are intended for the indications that each is approved to treat, per the authorization from a specific country or region.Please note that not all listed medicines are available in all countries, and some are marketed by a partner.
Tisotumab vedotin
Disease area: Oncology
Epcoritamab
Disease area: Oncology
If you have questions about our medicines, you might be able to access further information by visiting a local ÐǺ£ÆåÅÆ website. Please note that we provide this information in compliance with local regulations. We recommend to always ask a healthcare professional for advice about medicines.To submit a specific request please contact our Medical Information team here.To report an adverse event please e-mail globaldrugsafety@genmab.comTo report a product complaint please e-mail productcomplaint@genmab.com
